In addition, however, Ang2 blocking agents had no adverse effect on pre-existing atherosclerosis, suggesting that Ang2-TIE2 signaling actions may be limited to the early stages of atherosclerosis. This evidence concerns the gene ANGPT2 and atherosclerosis.